bialoglowy

[UPDATED] CDPROJEKT CDR short position changes

Long
GPW:CDR   CDPROJEKT
This chart shows recent changes in short positions by 5 funds currently shorting CDR and how these changes likely affect the stock price. You can scroll the chart to the left to see earlier changes.

CDR short positions reported in KNF Short Selling Register stand at 3.21% (~3,3M shares) as of June 18th 2021 reporting date:

0,85%: Eminence Capital, LP
0,70%: Citadel Advisors LLC
0,60%: SCGE Management, L.P.
0,56%: Marshall Wace LLP
0,50%: Arrowstreet Capital (new!)

CDR as it is the most shorted stock on GPW, also it is one of the most traded stocks. Some analysts estimate that the actual short position could be as high as 16% of the free float, that is as high as 10M shares - reporting requirement starts from short selling position of minimum 0.50%, so there are likely many more funds shorting the stock that have not yet reached the reporting level.

The huge price drop after a very positive news on 16th June, i.e. announcement of return of Cyberpunk 2077 to PlayStation Store was used by short sellers to increase position and stop further stock price increase. Volume Accumulation Percentage Indicator (VAPI) shows strong sale of stock by short sellers.

Given that CDR is the most shorted stock on GPW and also one of the most popular, the large short position increases chances of short squeeze. High amount of borrowed shares could increase the stock price by over 20% when these positions are closed.

Note: Short Borrow Fee Rate (%) on OTGLY currently at around 5.42%, which is quite average.

This chart is based on the KNF data. The KNF Short Selling Register data for the Friday 18th June session will only be available on Monday 21st June:
- rss.knf.gov.pl/RssOu...tart2OuterView.xhtml

Disclaimer: The information is not intended to be and do not constitute financial advice, investment advice, trading advice or any other advice or recommendation of any sort.

My opinions and other information shared is not intended to be and do not constitute financial advice, investment advice, trading advice or any other advice or recommendation of any sort.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.